Green Tea Consumption and Serum Malondialdehyde-Modified LDL Concentrations in Healthy Subjects

Journal of the American College of Nutrition

Volumn 24, Issue 5, 2005, Pages 342-346

  Hirano Ohmori, Reiko ^a   Momiyama, Yukihiko ^a   Taniguchi, Hiroaki ^a   Yonemura, Atsushi ^a   Tamai, Seiichi ^a   Nakamura, Haruo ^a   Ohsuzu, Fumitaka ^a   Takahashi, Rie ^b   Kondo, Kazuo ^b   Umegaki, Keizo ^c  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b OCHANOMIZU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

Green tea; In vivo; LDL oxidation

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; 8 ISOPROSTAGLANDIN F2 ALPHA; CHOLESTEROL; GELATINASE A; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THROMBOXANE B2;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CORONARY ARTERY DISEASE; DIETARY INTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; TEA; THROMBOCYTE AGGREGATION; URINALYSIS;

ADULT; ANTIOXIDANTS; CATECHIN; CROSS-OVER STUDIES; DINOPROST; HUMANS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; METALLOPROTEASES; OXIDATION-REDUCTION; PLATELET AGGREGATION; TEA;

EID: 25144440958     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2005.10719483     Document Type: Article

References (32)

1. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic BS, Toshima H, Feskens EJM, Hollman PCH, Katan MB: Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155: 381-386, 1995.
2. Hirvonen T, Pietinen P, Virtanen M, Ovaskainen ML, Hakkinen S, Albanes D, Virtamo J: Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiol 12: 62-67, 2001.
3. Hertog MG, Feskens EJM, Hollman PCH, Katan MB, Kromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342: 1007-1011, 1993.
4. Sesso HD, Gaziano JM, Buring JE, Hennekens CH: Coffee and teaintake and the risk of myocardial infarction. Am J Epidemiol 149: 162-167, 1999.
5. Geleijnse JM, Launer LJ, Hofman A, Pols HAP, Witteman JCM: Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch Intern Med 159: 2170-2174, 1999.
6. Sasazuki S, Kodama H, Yoshimasu K, Liu Y, Washio M, Tanaka K, Tokunaga S, Kono S, Arai H, Doi Y, Kawano T, Nakagaki O, Takada K, Koyanagi S, Hiyamuta K, Nii T, Shirai K, Ideishi M, Arakawa K, Mohri M, Takeshita A: Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 10: 401-408, 2000.
7. Sano J, Inami S, Seimiya K, Ohba T, Sakai S, Takano T, Mizuno K: Effects of green tea intake on the development of coronary artery disease. Circ J 68: 665-670, 2004.
8. Hirano R, Momiyama Y, Takahashi R, Taniguchi H, Kondo K, Nakamura H, Ohsuzu F: Comparison of green tea intake in Japanese patients with and without angiographic coronary artery disease. Am J Cardiol 90: 1150-1153, 2002.
9. Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umegaki K, Hara Y, Ikeda M, Tomita T: Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr 131: 27-32, 2001.
10. Tijburg LBM, Wiseman SA, Meijer GW, Weststrate JA: Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis 135: 37-47, 1997.
11. Mangiapane H, Thomson J, Salter A, Brown S, Bell GD, White DA: The inhibition of the oxidation of low density lipoprotein by ()-catechin, a naturally occurring flavonoid. Biochem Pharmacol 43: 445-450, 1992.
12. Yang TTC, Koo MWL: Inhibitory effect of Chinese green tea on endothelial cell-induced LDL oxidation. Atherosclerosis 148: 67-73, 2000.
13. Kang WS, Lim IH, Yuk DY, Chung KH, Park JB, Yoo HS, Yun YP: Antithrombotic activities of green tea catechins and b-epigallocatechin gallate. Thromb Res 96: 229-237, 1999.
14. Pignatelli P, Pulcinelli FM, Celestini A, Lenti L, Ghiselli A, Gazzaniga PP, Violi F: The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr 72: 1150-1155, 2000.
15. Demeule M, Brossard M, Page M, Gingras D, Beliveau R: Matrix metalloproteinase inhibition by green tea catechins. Biochim Biophys Acta 1478: 51-60, 2000.
16. Maeda K, Kuzuya M, Cheng XW, Asai T, Kanda S, Tamaya-Mori N, Sasaki T, Shibata T, Iguchi A: Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Atherosclerosis 166: 23-30, 2003.
17. Kotani K, Maekawa M, Kanno T, Kondo A, Toda N, Manabe M: Distribution of immunoreactive malondialdehyde-modified lowdensity lipoprotein in human serum. Biochim Biophys Acta 1215: 121-125, 1994.
18. Umegaki K, Sugisawa A, Yamada K, Higuchi M: Analytical method of measuring tea catechins in human plasma by solid-phase extraction and HPLC with electrochemical detection. J Nutr Sci Vitaminol 47: 402-408, 2001.
19. van het Hof KH, de Boer HSM, Wiseman SA, Lien N, Weststrate JA, Tijburg LBM: Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 66: 1125-1132, 1997.
20. Princen HMG, van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg LB, Langius JA, Meinders AE, Pijl H: No effect of consumption of green and black tea on plasma lipid and antioxidant concentrations and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol 18: 833-841, 1998.
21. Miura Y, Chiba T, Miura S, Tomita I, Umegaki K, Ikeda M, Tomita T: Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: an ex vivo study in humans. J Nutr Biochem 11: 216-222, 2000.
22. Freese R, Basu S, Hietanen E, Nair J, Nakachi K, Bartsch H, Mutanen M: Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females. Eur J Nutr 38: 149-157, 1999.
23. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D: Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98: 1487-1494, 1998.
24. Tanaga K, Bujo H, Inoue M: Increased circulating malondialdehyde-modified LDL concentrations in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arterioscler Thromb Vasc Biol 22: 662-666, 2002.
25. Hodgson JM, Croft KD, Mori TA, Burke V, Beilin LJ, Puddey IB: Regular ingestion of tea does not inhibit in vivo lipid peroxidation in humans. J Nutr 132: 55-58, 2002.
26. Frei B, England L, Ames BN: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86: 6377-6381, 1989.
27. Reilly M, Delanty N, Lawson JA, FitzGerald GA: Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94: 19-25, 1996.
28. O'Reilly JD, Mallet AI, McAnlis GT, Young IS, Halliwell B, Sanders TA, Wiseman H: Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans. Am J Clin Nutr 73: 1040-1044, 2001.
29. Hu C, Kitts DD: Evaluation of antioxidant activity of epigallocatechin gallate in biphasic model systems in vitro. Mol Cell Biochem 218: 147-155, 2001.
30. Kajiya K, Kumazawa S, Nakayama T: Steric effects on interaction of tea catechins with lipid bilayers. Biosci Biotechnol Biochem 65: 2638-2643, 2001.
31. Hodgson JM, Puddey IB, Mori TA, Burke V, Baker RI, Beilin LJ: Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans. Eur J Clin Nutr 55: 881-886, 2001.
32. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, Ueno T, Sugi K, Imaizumi T: Peripheral blood concentrations of matrix metalloproteases-2 and-9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32: 368-372, 1998.